GENE ONLINE|News &
Opinion
Blog

2023-03-23|

Launching an Innovative Product, PlaClin-M, for Safe Environments in the Pandemic Era.

by GeneOnline
Share To

SEOUL, South Korea, March 23, 2023 /PRNewswire/ — CodeSteri, a leading provider of disinfection solutions, is proud to announce the launch of PlaClin-M, a revolutionary device designed to help ensure a clean and safe environment in offices, commercial establishments, and public spaces. CodeSteri started from the Korean government project to combat new infectious diseases by the incumbent professor and MD of Hanyang University Emergency Medicine, Seoul.

PlaClin-M is a revolutionary disinfection device developed by CodeSteri of South Korea that helps protect people from the spread of new infectious diseases, viruses and bacteria, etc. The device uses advanced plasma technology to quickly and effectively disinfect any surface and space in a matter of minutes.

CodeSteri, with a $4.2M grant from the Korean government, developed ‘PlaClin’ after 5 years of R&D efforts with top experts in related fields commencing from 2015 when Mers hit Korea hard. PlaClin was awarded as an “Innovative Product” by the Ministry of Science and ICT and patented in USA and Korea.

The PlaClin solution is widely used by public sector agencies in Korea. The ambulances run by the government gained a big increase in operational effectiveness and cost savings by reducing the wait (reuse) time of Covid-19 carrying ambulances after disinfection from 1~2 hour to 10 to 20 minutes by switching to the PlaClin solution.

PlaClin-M is a compact and easy-to-use device that can be quickly utilised in any space.

With enhanced mobility and cordless convenience, the PlaClin-M is well suited for the disinfection of cruise ships, airplanes, trains, subways, etc. where space can be easily infected with crowded people and needs to be disinfected within a short time. Such airlines as Korean Airlines, Japan Airlines, and other major airlines can benefit a lot from using innovative PlaClin solutions. If PlaClin-M is used in the disinfection of airlines, they can save a huge time in reusing the planes and cost paying to airports by reducing the disinfection time by more than half. Major cruise lines such as Carnival, Royal Caribbean, Norwegian, etc. can enjoy mass infection-free operation with PlaClin-M. They can offer more safe travel environments to their customers and cost saving to themselves.

New infectious diseases with high mortality and contagiousness occur periodically at intervals of 3 to 4 years worldwide and are expected to repeat in the future as evidenced by Swine Flu 2009, Ebola 2013, Mers 2015, and Covid 2019. With the current saturated vaccination rate of Covid-19 and unscientific, time and labor-consuming disinfection globally, an innovative technology of PlaClin solutions well deserves attention from other governments and leading companies in the efforts to safeguard our environments from the pandemic.

PlaClin solution is eco-friendly disinfection harmless to both humans and devices, with FDA and CE certifications. It offers wide protection from cold, flu, food poisoning, and tuberculosis to high levels of sterilization in intensive care units, operating rooms, etc. “As a life-saving technology in the post Covid-19 era, the PlaClin-M is the essential device that provides safe and hygienic environments for workplaces and public spaces,” said Tae Ho Lim Ph.D., founder, and CEO of CodeSteri received 4 awards from ministers and 2 CES Innovation Awards. PlaClin-M is available now for purchase on CodeSteri and amazon.com website.

JungChi Seo, PhD
misterjc69@gmail.com 
+82 10 5446 4996 

 
©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
Lunit AI Solutions to Power Samsung’s X-ray Devices for Advanced Chest Screening
2024-01-16
FDA Keynote Speaker in the Spotlight, CAR-T Industry Leaders Gather for Discussion-Join the 2024 GenScript Biotech Global Forum for a New Journey in Cell and Gene Therapy
2023-12-24
Innovent Announces Publication of Mazdutide (IBI362) Phase 2 Full Results in Chinese Patients with Overweight or Obesity in Nature Communications
2023-12-17
LATEST
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
Join Us for the SABPA OC/LA 16th Annual Biomedical Forum!
2024-04-16
Sequencing Revolution Spotlights the Titans of NGS Innovation
2024-04-16
EVENT
2024-04-20
16th SABPA OC/LA Annual Biomedical Forum
The Beckman Center, 100 Academy, Irvine, CA, 92617
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top